BioInnovation Institute Fonden
CVR: 41898666
Secondary names: BioInnovation Institute Foundation (Fond), BII-Fonden, BII Foundation (Fond)
The financial health of BioInnovation Institute Fonden appears robust, marked by significant profitability and a strong equity position. In 2025, the company reported a revenue of 87.9 million DKK and a profit of 191.7 million DKK, reflecting a notable increase in revenue from 64.8 million DKK in 2024, despite a decrease in profit during the same period. The equity has remained substantial, totaling 738.3 million DKK in 2025, indicating a solid foundation for future growth. Overall, the company is on a strong upward trajectory, showcasing impressive margins and a growing presence within the trust activities sector.
AI-generated summary
Overview
- Company type
- EFO
- Erhvervsdrivende fond
- Founded
- 1.12.2020
Details
- Capital
- 10.000.000 kr.
Contact
Advertising protectedPurpose
Fonden har til formål med almennyttigt sigte at eje og drive BioInnovation Institute og at fremme forskning, innovation og iværksætteri til gavn for almenheden, herunder ved at finansiere og støtte udvikling af opfindelser, opdagelser og selskaber inden for bioteknologi- og life science-sektoren, for derved at skabe et grundlag for vækst og jobskabelse inden for bioteknologi og life science. Fonden kan også yde støtte til andre almennyttige videnskabelige formål inden for bioteknologi og life science.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 87.9 mio. | 191.7 mio. | 882.2 mio. | 738.3 mio. | 126 | |
History
Ownership
Management
Directors
Board
Production units (1)
Similar companies
Companies in the same industry and area